Trellus Health plc (FRA:85Q)

Germany flag Germany · Delayed Price · Currency is EUR
0.0110
-0.0010 (-8.33%)
At close: Jan 23, 2026
-65.63%
Market Cap1.77M -66.9%
Revenue (ttm)305.69K +552.7%
Net Income-5.87M
EPS-0.04
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume1,119
Open0.0110
Previous Close0.0120
Day's Range0.0110 - 0.0110
52-Week Range0.0005 - 0.0325
Betan/a
RSI57.47
Earnings DateApr 24, 2026

About Trellus Health

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn’s Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York. [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 2020
Employees 18
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 85Q
Full Company Profile

Financial Performance

In 2024, Trellus Health's revenue was $114,000, an increase of 500.00% compared to the previous year's $19,000. Losses were -$7.78 million, 22.8% more than in 2023.

Financial numbers in USD Financial Statements